Page last updated: 2024-10-24

carbamazepine and Severe Combined Immunodeficiency

carbamazepine has been researched along with Severe Combined Immunodeficiency in 1 studies

Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.

Severe Combined Immunodeficiency: Group of rare congenital disorders characterized by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels. It is inherited as an X-linked or autosomal recessive defect. Mutations occurring in many different genes cause human Severe Combined Immunodeficiency (SCID).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Wong, JCY1
Li, PH1

Other Studies

1 other study available for carbamazepine and Severe Combined Immunodeficiency

ArticleYear
Carbamazepine-induced B-cell aplasia: Overlooked and overtreated.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2020, Volume: 124, Issue:1

    Topics: Adult; Agammaglobulinemia; B-Lymphocytes; Carbamazepine; Drug Hypersensitivity; Female; Humans; Immu

2020